Approaches for timeline reductions in pathogenesis studies using genetically modified mice
Samantha Skavicus(Duke University), Nicholas S. Heaton(Duke University)
Cited by 9
Related Papers
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
|bioRxiv (Cold Spring Harbor Laboratory)|2020|63